U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07335601) titled 'Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH' on Jan. 07.
Brief Summary: A Phase 2 double-blind, randomized, placebo-controlled study to evaluate resmetirom in 2 cohorts of subjects with moderate to advanced fibrosis, consistent with stage F2 and F3 fibrosis, who have undergone liver transplant. Cohort 1 will consist of patients who have undergone liver transplant for MASH cirrhosis who developed recurrent MASH. Cohort 2 will consist of subjects who have undergone liver transplant for indications other than MASH cirrhosis who developed de novo MASH.
Study Start Date: Dec. 29, 2025
Study Type: INTERVENTI...